The FDA's Assessment of Two Drugs for Chronic Weight Management

被引:131
作者
Colman, Eric [1 ]
Golden, Julie [1 ]
Roberts, Mary [1 ]
Egan, Amy [1 ]
Weaver, Joyce [1 ]
Rosebraugh, Curtis [1 ]
机构
[1] US FDA, Silver Spring, MD USA
关键词
D O I
10.1056/NEJMp1211277
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
[No abstract available]
引用
收藏
页码:1577 / 1579
页数:3
相关论文
共 4 条
[1]
[Anonymous], 2007, GUID IND DEV PROD WE
[2]
[Graham D. FDA CDER FDA CDER], 1999, ENDOCRINOLOGIC METAB, V72, P94
[3]
Use of topiramate in pregnancy and risk of oral clefts [J].
Margulis, Andrea V. ;
Mitchell, Allen A. ;
Gilboa, Suzanne M. ;
Werler, Martha M. ;
Mittleman, Murray A. ;
Glynn, Robert J. ;
Hernandez-Diaz, Sonia .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2012, 207 (05) :405.e1-405.e7
[4]
Serotonergic drugs and valvular heart disease [J].
Rothman, Richard B. ;
Baumann, Michael H. .
EXPERT OPINION ON DRUG SAFETY, 2009, 8 (03) :317-329